OGEN Annual FCF
-$8.29 M
+$7.07 M+46.01%
31 December 2023
Summary:
As of January 22, 2025, OGEN annual free cash flow is -$8.29 million, with the most recent change of +$7.07 million (+46.01%) on December 31, 2023. During the last 3 years, it has risen by +$8.66 million (+51.09%). OGEN annual FCF is now -553.24% below its all-time high of -$1.27 million, reached on December 31, 2003.OGEN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OGEN Quarterly FCF
-$1.97 M
-$425.80 K-27.57%
30 September 2024
Summary:
As of January 22, 2025, OGEN quarterly free cash flow is -$1.97 million, with the most recent change of -$425.80 thousand (-27.57%) on September 30, 2024. Over the past year, it has dropped by -$867.80 thousand (-78.71%). OGEN quarterly FCF is now -1490.23% below its all-time high of -$123.90 thousand, reached on March 31, 2003.OGEN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OGEN TTM FCF
-$7.68 M
-$467.30 K-6.48%
30 September 2024
Summary:
As of January 22, 2025, OGEN TTM free cash flow is -$7.68 million, with the most recent change of -$467.30 thousand (-6.48%) on September 30, 2024. Over the past year, it has dropped by -$390.70 thousand (-5.36%). OGEN TTM FCF is now -6099.76% below its all-time high of -$123.90 thousand, reached on March 31, 2003.OGEN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OGEN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.0% | -78.7% | -5.4% |
| 3 y3 years | +51.1% | -78.7% | -5.4% |
| 5 y5 years | +9.9% | -78.7% | -5.4% |
OGEN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.0% | -78.7% | +65.6% | -6.5% | +52.6% |
| 5 y | 5-year | at high | +51.1% | -78.7% | +65.6% | -6.5% | +56.0% |
| alltime | all time | -553.2% | +51.1% | -1490.2% | +65.6% | -6099.8% | +56.0% |
Oragenics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.97 M(+27.6%) | -$7.68 M(+6.5%) |
| June 2024 | - | -$1.54 M(-49.6%) | -$7.21 M(-12.5%) |
| Mar 2024 | - | -$3.06 M(+177.9%) | -$8.25 M(+13.1%) |
| Dec 2023 | -$8.29 M(-46.0%) | -$1.10 M(-26.6%) | -$7.29 M(-15.5%) |
| Sept 2023 | - | -$1.50 M(-41.7%) | -$8.62 M(-21.1%) |
| June 2023 | - | -$2.58 M(+22.2%) | -$10.93 M(-6.9%) |
| Mar 2023 | - | -$2.11 M(-13.4%) | -$11.74 M(-23.5%) |
| Dec 2022 | -$15.36 M(+13.6%) | -$2.44 M(-36.1%) | -$15.36 M(-0.4%) |
| Sept 2022 | - | -$3.81 M(+12.7%) | -$15.42 M(-4.9%) |
| June 2022 | - | -$3.38 M(-40.9%) | -$16.22 M(+8.7%) |
| Mar 2022 | - | -$5.72 M(+128.6%) | -$14.91 M(+10.3%) |
| Dec 2021 | -$13.51 M(-20.3%) | -$2.50 M(-45.6%) | -$13.51 M(-7.7%) |
| Sept 2021 | - | -$4.60 M(+121.5%) | -$14.64 M(-0.4%) |
| June 2021 | - | -$2.08 M(-52.0%) | -$14.70 M(-15.8%) |
| Mar 2021 | - | -$4.33 M(+19.2%) | -$17.46 M(+3.0%) |
| Dec 2020 | -$16.95 M(+30.0%) | -$3.63 M(-22.2%) | -$16.95 M(-1.8%) |
| Sept 2020 | - | -$4.67 M(-3.5%) | -$17.27 M(+8.1%) |
| June 2020 | - | -$4.83 M(+26.4%) | -$15.98 M(+9.1%) |
| Mar 2020 | - | -$3.82 M(-3.2%) | -$14.65 M(+12.4%) |
| Dec 2019 | -$13.04 M(+41.6%) | -$3.95 M(+17.0%) | -$13.04 M(+7.5%) |
| Sept 2019 | - | -$3.38 M(-3.5%) | -$12.13 M(+7.7%) |
| June 2019 | - | -$3.50 M(+58.3%) | -$11.27 M(+12.1%) |
| Mar 2019 | - | -$2.21 M(-27.3%) | -$10.05 M(+9.2%) |
| Dec 2018 | -$9.20 M(+44.6%) | -$3.04 M(+21.0%) | -$9.20 M(+22.4%) |
| Sept 2018 | - | -$2.51 M(+10.3%) | -$7.52 M(+18.5%) |
| June 2018 | - | -$2.28 M(+66.9%) | -$6.35 M(+8.8%) |
| Mar 2018 | - | -$1.37 M(+0.6%) | -$5.83 M(-8.4%) |
| Dec 2017 | -$6.36 M(-10.4%) | -$1.36 M(+1.4%) | -$6.36 M(-8.7%) |
| Sept 2017 | - | -$1.34 M(-24.1%) | -$6.97 M(-3.6%) |
| June 2017 | - | -$1.76 M(-7.1%) | -$7.23 M(-2.1%) |
| Mar 2017 | - | -$1.90 M(-3.2%) | -$7.38 M(+4.0%) |
| Dec 2016 | -$7.10 M(+34.2%) | -$1.96 M(+22.9%) | -$7.10 M(+4.4%) |
| Sept 2016 | - | -$1.60 M(-16.8%) | -$6.80 M(+4.5%) |
| June 2016 | - | -$1.92 M(+18.5%) | -$6.51 M(+17.2%) |
| Mar 2016 | - | -$1.62 M(-2.5%) | -$5.55 M(+4.9%) |
| Dec 2015 | -$5.29 M(-6.7%) | -$1.66 M(+27.4%) | -$5.29 M(+8.0%) |
| Sept 2015 | - | -$1.30 M(+35.1%) | -$4.90 M(+4.4%) |
| June 2015 | - | -$965.30 K(-29.1%) | -$4.70 M(-13.5%) |
| Mar 2015 | - | -$1.36 M(+7.0%) | -$5.43 M(-4.3%) |
| Dec 2014 | -$5.67 M(-16.4%) | -$1.27 M(+15.7%) | -$5.67 M(+0.9%) |
| Sept 2014 | - | -$1.10 M(-35.2%) | -$5.62 M(-13.5%) |
| June 2014 | - | -$1.70 M(+5.8%) | -$6.50 M(-4.6%) |
| Mar 2014 | - | -$1.60 M(+31.3%) | -$6.81 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$6.78 M(+29.9%) | -$1.22 M(-38.2%) | -$6.78 M(-7.1%) |
| Sept 2013 | - | -$1.98 M(-1.6%) | -$7.30 M(+12.3%) |
| June 2013 | - | -$2.01 M(+26.9%) | -$6.51 M(+15.2%) |
| Mar 2013 | - | -$1.58 M(-9.2%) | -$5.65 M(+8.4%) |
| Dec 2012 | -$5.22 M(-4.9%) | -$1.74 M(+47.8%) | -$5.21 M(+7.2%) |
| Sept 2012 | - | -$1.18 M(+2.4%) | -$4.86 M(-6.5%) |
| June 2012 | - | -$1.15 M(+0.6%) | -$5.20 M(-5.6%) |
| Mar 2012 | - | -$1.14 M(-17.8%) | -$5.51 M(+0.4%) |
| Dec 2011 | -$5.49 M(-15.9%) | -$1.39 M(-8.4%) | -$5.49 M(-5.0%) |
| Sept 2011 | - | -$1.52 M(+3.9%) | -$5.78 M(-0.9%) |
| June 2011 | - | -$1.46 M(+30.0%) | -$5.83 M(+1.6%) |
| Mar 2011 | - | -$1.12 M(-33.1%) | -$5.74 M(-12.2%) |
| Dec 2010 | -$6.54 M(+12.5%) | -$1.68 M(+7.2%) | -$6.54 M(+4.7%) |
| Sept 2010 | - | -$1.57 M(+14.7%) | -$6.24 M(-11.9%) |
| June 2010 | - | -$1.37 M(-28.8%) | -$7.09 M(+7.4%) |
| Mar 2010 | - | -$1.92 M(+38.6%) | -$6.59 M(+13.5%) |
| Dec 2009 | -$5.81 M(+49.3%) | -$1.39 M(-42.5%) | -$5.81 M(-2.1%) |
| Sept 2009 | - | -$2.41 M(+175.3%) | -$5.93 M(+33.2%) |
| June 2009 | - | -$875.90 K(-22.8%) | -$4.45 M(-0.9%) |
| Mar 2009 | - | -$1.14 M(-24.7%) | -$4.49 M(+15.5%) |
| Dec 2008 | -$3.89 M(+101.9%) | -$1.51 M(+61.4%) | -$3.89 M(+37.0%) |
| Sept 2008 | - | -$934.10 K(+1.9%) | -$2.84 M(+20.0%) |
| June 2008 | - | -$916.90 K(+72.4%) | -$2.36 M(+15.8%) |
| Mar 2008 | - | -$531.90 K(+16.6%) | -$2.04 M(+6.0%) |
| Dec 2007 | -$1.93 M(-13.9%) | -$456.10 K(-0.8%) | -$1.93 M(-1.0%) |
| Sept 2007 | - | -$460.00 K(-22.6%) | -$1.95 M(+1.6%) |
| June 2007 | - | -$594.00 K(+42.6%) | -$1.92 M(+0.2%) |
| Mar 2007 | - | -$416.60 K(-12.5%) | -$1.91 M(-14.5%) |
| Dec 2006 | -$2.24 M(-45.5%) | -$476.30 K(+11.2%) | -$2.24 M(-2.5%) |
| Sept 2006 | - | -$428.50 K(-27.4%) | -$2.29 M(-11.4%) |
| June 2006 | - | -$590.20 K(-20.4%) | -$2.59 M(-13.6%) |
| Mar 2006 | - | -$741.60 K(+38.8%) | -$3.00 M(-26.9%) |
| Dec 2005 | -$4.10 M(+19.3%) | -$534.20 K(-26.2%) | -$4.10 M(-14.2%) |
| Sept 2005 | - | -$724.00 K(-27.5%) | -$4.78 M(-2.2%) |
| June 2005 | - | -$998.40 K(-45.9%) | -$4.89 M(+3.8%) |
| Mar 2005 | - | -$1.84 M(+51.8%) | -$4.71 M(+37.1%) |
| Dec 2004 | -$3.44 M(+170.7%) | -$1.22 M(+45.9%) | -$3.44 M(+28.7%) |
| Sept 2004 | - | -$833.00 K(+1.8%) | -$2.67 M(+20.2%) |
| June 2004 | - | -$818.50 K(+43.8%) | -$2.22 M(+29.4%) |
| Mar 2004 | - | -$569.30 K(+27.1%) | -$1.71 M(+35.1%) |
| Dec 2003 | -$1.27 M | -$447.90 K(+16.7%) | -$1.27 M(+54.5%) |
| Sept 2003 | - | -$383.80 K(+22.3%) | -$821.40 K(+87.7%) |
| June 2003 | - | -$313.70 K(+153.2%) | -$437.60 K(+253.2%) |
| Mar 2003 | - | -$123.90 K | -$123.90 K |
FAQ
- What is Oragenics annual free cash flow?
- What is the all time high annual FCF for Oragenics?
- What is Oragenics annual FCF year-on-year change?
- What is Oragenics quarterly free cash flow?
- What is the all time high quarterly FCF for Oragenics?
- What is Oragenics quarterly FCF year-on-year change?
- What is Oragenics TTM free cash flow?
- What is the all time high TTM FCF for Oragenics?
- What is Oragenics TTM FCF year-on-year change?
What is Oragenics annual free cash flow?
The current annual FCF of OGEN is -$8.29 M
What is the all time high annual FCF for Oragenics?
Oragenics all-time high annual free cash flow is -$1.27 M
What is Oragenics annual FCF year-on-year change?
Over the past year, OGEN annual free cash flow has changed by +$7.07 M (+46.01%)
What is Oragenics quarterly free cash flow?
The current quarterly FCF of OGEN is -$1.97 M
What is the all time high quarterly FCF for Oragenics?
Oragenics all-time high quarterly free cash flow is -$123.90 K
What is Oragenics quarterly FCF year-on-year change?
Over the past year, OGEN quarterly free cash flow has changed by -$867.80 K (-78.71%)
What is Oragenics TTM free cash flow?
The current TTM FCF of OGEN is -$7.68 M
What is the all time high TTM FCF for Oragenics?
Oragenics all-time high TTM free cash flow is -$123.90 K
What is Oragenics TTM FCF year-on-year change?
Over the past year, OGEN TTM free cash flow has changed by -$390.70 K (-5.36%)